Literature DB >> 15182728

Malondialdehyde-acetaldehyde haptenated protein binds macrophage scavenger receptor(s) and induces lysosomal damage.

Monte S Willis1, Lynell W Klassen, Deborah L Carlson, Chad F Brouse, Geoffrey M Thiele.   

Abstract

There is evidence that the chemical modification of proteins (haptens) with malondialdehyde-acetaldehyde (MAA) and the immune response to these haptenated proteins is associated with the initiation and/or progression of alcohol liver disease. Experimentally, proteins modified with MAA induce antibody and T cell responses, which are mediated by scavenger receptor(s). Moreover, macrophages have been shown to play an important role in processing and presenting MAA-haptenated proteins in vitro. In vitro, MAA-modified proteins have been shown to induce both apoptosis and necrosis in a dose- and cell-type-dependent manner. Natural ligands modified by oxidative stress, such as oxidized LDL, similarly initiate not only antibody responses, but also cause cell death by disrupting lysosomes after binding to scavenger receptors and internalization. We therefore investigated the binding, internalization, and lysosomal integrity in a macrophage cell line to a MAA-haptenated protein. We demonstrate for the first time that MAA-haptenated proteins are preferentially bound by scavenger receptors on macrophages, which internalize the ligands and shuttle them to lysosomes. Moreover, MAA-haptenated proteins are demonstrated to be associated with a rapid dose-dependent disruption in lysosomal integrity, resulting in leakage and caspase activation. Similarly, as hen egg lysozyme (HEL)-MAA concentrations increased (>31.3 microg/ml), increased levels of apoptosis and a G1/S cell cycle checkpoint inhibition were identified. This study identifies mechanisms by which MAA-haptenated proteins are taken up by a representative antigen-presenting cell and may delineate steps by which MAA-haptenated proteins induce cell death and induce their immunogenicity to the carrier protein. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182728     DOI: 10.1016/j.intimp.2004.04.004

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

1.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 2.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

4.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

5.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

6.  Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging.

Authors:  Matthew C Zimmerman; Dahn L Clemens; Michael J Duryee; Cleofes Sarmiento; Andrew Chiou; Carlos D Hunter; Jun Tian; Lynell W Klassen; James R O'Dell; Geoffrey M Thiele; Ted R Mikuls; Daniel R Anderson
Journal:  Redox Biol       Date:  2017-08-02       Impact factor: 11.799

7.  Malondialdehyde-acetaldehyde (MAA) adducted surfactant protein induced lung inflammation is mediated through scavenger receptor a (SR-A1).

Authors:  Muna Sapkota; Jane M DeVasure; Kusum K Kharbanda; Todd A Wyatt
Journal:  Respir Res       Date:  2017-02-13

Review 8.  Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.

Authors:  N Papac-Milicevic; C J-L Busch; C J Binder
Journal:  Adv Immunol       Date:  2016-04-05       Impact factor: 3.543

Review 9.  Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.

Authors:  Antonio Ayala; Mario F Muñoz; Sandro Argüelles
Journal:  Oxid Med Cell Longev       Date:  2014-05-08       Impact factor: 6.543

10.  Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.

Authors:  Daniel R Anderson; Michael J Duryee; Scott W Shurmur; John Y Um; Walter D Bussey; Carlos D Hunter; Robert P Garvin; Harlan R Sayles; Ted R Mikuls; Lynell W Klassen; Geoffrey M Thiele
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.